lobbying_activities: 925431

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
925431	f3ed38ac-ae6a-4b5b-9947-5e0c6aaf89b2	Q1	AMYLIN PHARMACEUTICALS	308536	AMYLIN PHARMACEUTICALS	2010	first_quarter	PHA	Physician Payments Sunshine provision of HR 3590 the Patient Protection and Affordable Care Act and H.R.4872 the Health Care and Education Reconciliation Act of 2010 FDA Risk Evaulation Mitigation Strategies (REMS) Drug Safety Communications Drug importation issues in HR 3590 the Patient Protection and Affordable Care Act and H.R.4872 the Health Care and Education Reconciliation Act of 2010	HOUSE OF REPRESENTATIVES,SENATE		320000	0	0	2010-04-19T18:02:38.087000-04:00